预测因素和阿达利木马布在治疗慢性复发Vogt-Koyanagi-Harada疾病中的有效性
Hui Feng1, Weixin Chen1, Jianzhu Yang1
1Beijing Ophthalmology and Visual Sciences Key Laboratory, Beijing Tongren Hospital, Beijing Tongren Eye Center, Beijing Institute of Ophthalmology, Capital Medical University, Beijing, China.
BMC ophthalmology
|June 7, 2024
概括
年龄较大和"日落发光底部"预测了Vogt-Koyanagi-Harada (VKH) 疾病的复发. 阿达利穆马布 (ADA) 有效治疗慢性VKH,降低炎症和复发率.
科学领域:
- 眼科医生 眼科 眼科
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 沃格特-科亚纳吉-哈拉达病 (VKH) 是一种影响眼组织的全身性炎症状况.
- 了解预后因素对于管理VKH疾病进展至关重要.
- 目前正在评估Adalimumab (ADA) 对治疗复发性VKH的疗效.
研究的目的:
- 确定与VKH疾病向慢性复发期进展相关的预后因素.
- 评估Adalimumab (ADA) 在治疗复发性VKH疾病中的疗效和安全性.
主要方法:
- 对62名在2020-2023年期间被诊断为VKH患者的回顾性研究.
- 分析临床数据,包括视力敏度,年龄,眼部并发症和复发情况.
- 后勤回归用于识别慢性复发的预测因素.
主要成果:
- 慢性复发的VKH患者年龄较大,初始视力敏度较差,与急性解决的患者相比.
- "日落发光底部"在慢性复发组 (64.3%) 更为普遍,并预测了进展.
- 在慢性复发性VKH患者中,阿达利马布 (ADA) 显著降低了眼部炎症和复发率.
结论:
- 发病时的年龄较大和"日落发光底部"是VKH疾病慢性化的重要预测因素.
- 阿达利穆马布 (ADA) 在治疗耐火性VKH方面表现出有效性,减少炎症和复发.
- 对于慢性复发性VKH疾病来说,ADA是一种耐受良好的治疗选择.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
130
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
157
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
157
Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
Pharmacovigilance
825
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
825
Autoimmune Disorders
417
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
417
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115


